Source: Pharmacy Times articles
Gabriel Hinojosa, PharmD, BCOP, looks beyond frontline regimens in multiple myeloma, and discusses treatment options, adverse events, and complexities in sequencing therapies.
Read More
by | Feb 7, 2024 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Gabriel Hinojosa, PharmD, BCOP, looks beyond frontline regimens in multiple myeloma, and discusses treatment options, adverse events, and complexities in sequencing therapies.
Read More